isis pharmaceuticals inc
(ISIS:NASDAQ GS)
Executive Profile*
B. Lynne Parshall Esq., J.D.Chief Operating Officer, Secretary and Director, Isis Pharmaceuticals, Inc. |
| Age | Total Calculated Compensation | This person is connected to 50 board members in 4 different organizations across 5 different industries. See Board Relationships |
| 56 | $1,171,615 As of Fiscal Year 2012 |
Background*
Ms. B. Lynne Parshall, Esq., J.D. has been the Chief Operating Officer of Isis Pharmaceuticals, Inc. since December 2007 and also serves as its Secretary. Ms. Parshall served as Chief Financial Officer since June 1994 and also serves as its Principal Accounting Officer and Secretary. Ms. Parshall is responsible for overseeing the operations of finance, legal, patents, manufacturing and business development and is also involved in Isis Pharmaceuticals, Inc.’s corporate ...
Corporate Headquarters*2855 Gazelle CourtCarlsbad, California 92010 United States Phone: 760-931-9200 Fax: -- Board Members Memberships*Board Member Former Director 2000-Present Chief Operating Officer, Secretary and Director 2005-Present Director, Chairman of Audit Committee and Member of Nominating & Governance Committee 2005-N/A Former Director and Chairman of Audit Committee 2009-Present Director and Chairman of Audit Committee 2013-Present Director and Member of Audit Committee
Education*BA Harvard University JD Stanford University Law school
Other Affiliations* |
Annual Compensation*
Stock Options*
Total Compensation*
|
| Recently Viewed | |||
| ISIS:US | $20.64 USD | +0.25 | |
COMPETITOR COMPENSATION
| Name | Position/ Company | Compensation |
| George W. Hebard III, M.B.A | Interim Principal Executive Officer, Interim Chief Operating Officer and Director Enzon Pharmaceuticals Inc. | $226.4K |
| Christopher Nishan Garabedian | Chief Executive Officer, President and Director Sarepta Therapeutics, Inc. | $490.0K |
| John M. Maraganore Ph.D. | Chief Executive Officer and Executive Director Alnylam Pharmaceuticals, Inc. | $669.5K |
| Kleanthis G. Xanthopoulos Ph.D. | Chief Executive Officer, President and Director Regulus Therapeutics Inc. | $515.5K | Compensation as of Fiscal Year 2012. |
Post a JobJobs
- Carlsbad, CA | ISIS PharmaceuticalsPosted: May 06
- San Diego, CA | ISIS PharmaceuticalsPosted: May 23
- San Diego, CA | ISIS PharmaceuticalsPosted: Apr 04
Sponsored Financial Commentaries
Sponsored Links
To contact ISIS PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








